Navigation Links
Poniard Pharmaceuticals Announces Promising Data From Interim,Safety Analysis of Phase 1 Combination Trials of Picoplatin in,Colorectal and Prostate Cancers

ceived orphan drug designation from the FDA in November 2005 for picoplatin for the treatment of SCLC. An oral formulation of picoplatin is being evaluated in a Phase 1 clinical trial.

About Poniard Pharmaceuticals

Poniard Pharmaceuticals, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of innovative oncology products to impact the lives of people with cancer. The Company's lead drug product candidate is picoplatin, which is currently being studied in clinical trials for the treatment of small cell lung, colorectal and hormone-refractory prostate cancers. As part of the Company's strategic goal of building a diverse oncology pipeline, the Company is collaborating with The Scripps Research Institute on the discovery of novel, small-molecule, multi-targeted protein kinase inhibitors. For additional information please visit http://www.poniard.com.

This release contains forward-looking statements, including statements regarding the Company's business objectives and strategic goals, drug development plans, and efficacy of its products in development. The Company's actual results may differ materially from those indicated in these forward- looking statements based on a number of factors, including risks and uncertainties associated with the Company's research and development activities; the results of pre-clinical and clinical testing; the receipt and timing of required regulatory approvals; the market's acceptance of its proposed product; the Company's anticipated operating losses, need for future capital and ability to obtain future funding; competition from third parties; the Company's ability to preserve and protect intellectual property rights; the Company's dependence on third-party manufacturers and suppliers; the Company's lack of sales and marketing experience; the Company's ability to attract and retain key personnel; changes in technology,
'"/>




Page: 1 2 3 4 5 6

Related medicine technology :

1. Poniard Pharmaceuticals Announces Clinical Data from Picoplatin Phase 2 Small Cell Lung Cancer Trial To Be Presented at American Society of Clinical Oncology Annual Meeting
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
6. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
7. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
8. Pro-Pharmaceuticals Updates Progress of Clinical Trials & Davanat 505 (b)(2) Filings
9. Cosmo Pharmaceuticals Reports Positive Preliminary Phase II/III Data with Rifamycin MMX in Infectious Diarrhea
10. Portola Pharmaceuticals Announces Positive Phase II EXPERT Results and Additional Oral and Poster Presentations at the XXI Congress of the International Society on Thrombosis and Haemostasis (ISTH)
11. Cyclacel Pharmaceuticals Announces Results of Phase II Seliciclib Combination Studies
Post Your Comments:
(Date:5/24/2013)... , May 24, 2013 Solta Medical, Inc. ... medical aesthetics market, today reported Dr. Edward W. ... Company,s Board of Directors effective immediately.  Dr. Knowlton is the ... had served as a director since 1996. "On ... our management team, I would like to thank Ed for ...
(Date:5/24/2013)... Corporation (NASDAQ: HSKA, "Heska" or the "Company"), a leading provider ... Robert Grieve , the Company,s chairman and ... executive vice president and chief financial officer, will present at ... May 30, 2013 in New York City ... Company,s presentation is scheduled to begin at 1:30 p.m. EDT. ...
(Date:5/24/2013)... May 24, 2013  Auxilium Pharmaceuticals, Inc. (Nasdaq: ... participate in the Deutsche Bank Health Care Conference to ... Hotel.  Mr. Adrian Adams , Chief ... overview of the Company and its product pipeline at ... (Logo: http://photos.prnewswire.com/prnh/20101202/MM10881LOGO ) The ...
Breaking Medicine Technology:Dr. Edward W. Knowlton Resigns as a Director of Solta Medical, Inc. 2Heska Corporation To Present At The Second Annual Marcum LLP MicroCap Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 2Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 3Auxilium Pharmaceuticals, Inc. To Present At The Deutsche Bank Health Care Conference 4
... 26, 2011 Sysmex, a global leader in ... today announced that Andrew (Andy) Hay has been ... effective immediately.  Hay, a long-time Sysmex employee, is ... corporate accounts, sales training and sales operational activities ...
... The virtual event Design Trends: Technological Advances in Implantable ... until 5pm Eastern time. Registration is available here ... The combined virtual conference and tradeshow kicks-off this ... address by Venkat Rajan, Industry Manager of Medical Devices ...
Cached Medicine Technology:Sysmex America Appoints Vice President of Sales 2Live Today: Virtual Event Dedicated to Cutting-Edge Trends in Implantable Medical Devices 2
(Date:5/25/2013)... (PRWEB) May 25, 2013 Radius ... underground shelter company in the US and has ... structures for over 35 years. M.E. and President, ... Handbook of NBC Weapon Fundamentals and Shelter Engineering ... States’ bible on shelter engineering. McCarthy is considered ...
(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 On ... that many people do not wish to discuss or plan ... in life. FuneralFinancials.com released a Must-Do List ... , 1. Funeral Financials recommends, “Creating a personal fact sheet.” ... used to organize financial information and personal data. It ...
(Date:5/25/2013)... York, NY (PRWEB) May 25, 2013 ... dedicated to brain cancer research and advocacy, comments on ... Extraterrestrial Physics, that shows incorporating cold atmospheric plasma into ... cells. , According to a Science Daily ... Extraterrestrial Physics (MPE), biologists and physicians demonstrated the “synergistic ...
(Date:5/25/2013)... According to world-renowned scholars, Queen Cleopatra ... women that ever lived. Cleopatra’s legendary beauty moved nations ... most powerful men in her time. Cleopatra was also ... her skin glowing and fresh, from her legendary milk ... oil and cyprus grass. , Cleopatra was said to ...
(Date:5/25/2013)... Prairie Living at Chautauqua , a BMA ... Cross Blood Drive from 1:30 to 5:30 p.m. on ... at 955 Villa Ct. in Carbondale, Illinois, serves older ... need some help to maintain their independence.. , "Come ... Frey, Director of Marketing for Prairie Living. , For ...
Breaking Medicine News(10 mins):Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 2Health News:Radius Engineering International Inc. Offers Tools to Stay Safe and Recover From Any Disaster 3Health News:FuneralFinancials.com Releases Last Wishes Must-Do List 2Health News:Voices Against Brain Cancer Comments on Study that Shows Cold Plasma’s Success Against Brain Cancer Cells 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 2Health News:The Cleopatra Lift - A New Non Surgical Option to Aging Offered by Vancouver Physician 3Health News:Carbondale Affordable Assisted Living Community to Host Red Cross Blood Drive 2
... ... ... ... ...
... Freedom Healthnet today ... of new products. , ... UK (PRWEB) February 19, 2010 -- Freedom Healthnet ( http://www.freedomhealthnet.com/ ) today affirmed the benefits ... , ,Freedom Healthnet is already a market leader in the UK for health insurance, providing ...
... ... present a talk on the False Claims Act to the Great Salt Lake Chapter of ... Clearfield. Terry will discuss the "nuts and bolts" of the False Claims Act, its ... ...
... ... ... ... ...
... , ... ... ... ...
... ... a partnership agreement with Genentech, Inc., a wholly owned member of the Roche Group, ... ... of California, San Francisco has signed a partnership agreement with Genentech, Inc., a wholly ...
Cached Medicine News:Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 2Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 3Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 4Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 5Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 6Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 7Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 8Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 9Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 10Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 11Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 12Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 13Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 14Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 15Health News:Nuvo Research announces 2009 fourth quarter and year-end financial results 16Health News:Freedom Healthnet Affirms Affordable Private Health Insurance Benefits 2Health News:Great Salt Lake Chapter of National Contract Management Association Hosts Presentation on False Claims Act by Qui Tam Attorney Tim Terry 2Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 2Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 3Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 4Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 5Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 6Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 7Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 8Health News:FDA Cancer Drug Approval Rate Highlighted in JNCI 9Health News:Centene Corporation to Webcast Medical Management Systems Update 2Health News:Centene Corporation to Webcast Medical Management Systems Update 3Health News:Centene Corporation to Webcast Medical Management Systems Update 4Health News:UCSF Enters Drug Discovery Agreement with Genentech 2Health News:UCSF Enters Drug Discovery Agreement with Genentech 3Health News:UCSF Enters Drug Discovery Agreement with Genentech 4
... the new large power line from ... both cordless AND electric instruments, offering ... versatility the industry has always wanted ... name. Power Master reciprocating ...
The 7700 Reciprocating Saw completes the large power system with our simple twist-lock blade hub and selection of saw blades....
The 7500 Drill/Reamer operates at two speeds for multiple applications, which is automatically controlled by the 16 different coupler attachments. The drill reamer can be used for, but is not limited...
... The SmartDriver System consists of a ... Battery Power, with a wide range of ... variety of orthopedic surgical applications., ,The ... and speed compared to the original Battery ...
Medicine Products: